Plastic Surgery Private Equity Deals

One of Healthcare’s Fastest-Growing M&A Categories

Plastic surgery has emerged as one of private equity’s most actively pursued physician practice niches. Sitting at the intersection of insurance-reimbursed reconstructive procedures and high-margin, cash-pay aesthetics, plastic surgery practices offer the recession-resilient earnings and margin profile that PE buyers prize.

Deal Volume: A Specialty on the Rise

According to the VMG Health 2025 Healthcare M&A Report, plastic surgery was among the most significant “large movers” in physician medical group consolidation in 2024. Deal volume grew dramatically over a two-year span:1

Plastic Surgery Deal Volume: 2022-2024

That 440% increase over two years put plastic surgery alongside ophthalmology and dermatology as one of the fastest-consolidating specialties in physician services. For context, broader physician medical group M&A totaled approximately 430 transactions in 2024, with private equity sponsoring 280 of them, representing 58.4% of all deals in the sector.1

PE Share of Physician Medical Group Deals (PitchBook Data)

The Broader PE Backdrop

Healthcare services PE deal activity has moderated since its 2021 peak, but remains structurally active. According to PitchBook’s Q3 2025 Healthcare Services Report, total annual deal counts have trended from a high of 1,218 in 2021 to an estimated 536-678 range in 2024-2025.2

Healthcare Services PE Deal Count (Annual)

Despite declining deal counts, physician practice management (PPM) remains a core deployment target. PitchBook’s 2026 Healthcare Outlook explicitly identifies PPMs and multispecialty clinics as “best positioned to benefit” from AI-driven operational improvements, identifying them as an “exclusive focus for deployment” heading into 2026.3

At the May 2025 Healthcare Capital Markets Summit, conference panelists confirmed medspa and aesthetics as one of the most actively discussed subsectors in healthcare services PE, alongside behavioral health, infusion, and home-based care.4

Comparable Transaction Benchmarks

Because plastic surgery practices blend physician group and aesthetics economics, the most instructive valuation benchmarks span both categories. The following publicly documented transactions illustrate where buyers have priced healthcare services assets:

Select Healthcare Services Transaction Benchmarks

Note: Plastic surgery-specific private transaction multiples are not published in available PitchBook reports. The above comps represent the pricing range within which plastic surgery practices likely transact, depending on scale, cash-pay mix, and platform readiness.

Plastic surgery practices with significant aesthetic revenue and owned surgical facilities generally price above the ambulatory surgery medians shown above. Practices that achieve platform scale with multi-surgeon depth and ancillary services command pricing closer to the high end of the healthcare services range, adjusted for size, consistent with the premium the market assigns to cash-pay, consumer-facing healthcare models.

Medical Aesthetics: The Premium Catalyst

The market favors plastic surgery practices with a significant non-surgical aesthetics component. This is largely a carryover from private equity’s intense interest in medical aesthetics businesses. According to the VMG Health 2025 Healthcare M&A Report, 37 PE-backed medspa platforms were actively acquiring in 2024, completing 45 acquisitions during the calendar year.1 As Eugene Goldenberg, Managing Director at Edgemont Partners, noted at the McGuireWoods Healthcare Finance and Growth Conference in September 2024:

While new medspa platform formation has since slowed, plastic surgery practices with robust aesthetic revenue (body contouring, facial rejuvenation, injectables, medspa services) remain highly sought after. For example, PitchBook data confirms that DermCare Management, an aesthetics-linked dermatology platform, completed 22 add-on acquisitions since 2021, one of the highest totals among all PE-backed healthcare services companies.4

What Moves Value in a Plastic Surgery Transaction

2026 Outlook

PitchBook’s 2026 Healthcare Outlook forecasts a rebound in healthcare services M&A activity, with PPMs identified as structurally well-positioned for both operational improvement and deal activity.3 Key points for plastic surgery sellers:

For plastic surgery owners, the combination of strong cash-pay fundamentals, an active buyer universe, and impending PE exits creates a compelling window, especially for practices that have invested in multi-provider depth, owned facilities, and aesthetic service lines.

FOCUS Investment Banking provides sell-side M&A advisory for healthcare practice owners. To discuss your practice’s value and readiness for a transaction, contact our team here.

Sources